Efficacy of Racecadotril in Acute Watery Diarrhea in Children

NCT01577043 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2012-04-13

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of racecadotril in acute watery diarrhea in children. The investigators will evaluate the effect of product versus placebo.

Conditions

  • Acute Diarrhea
  • Acute Gastroenteritis

Interventions

DRUG

Racecadotril

Racecadotril, 30 mg per sachet, dosage 1.5 mg./kg./day

OTHER

Placebo

cornstarch powder diluted in distilled water, dosage 2.5 ml per dose

Sponsors & Collaborators

  • Centro Pediatrico Albina de Patino

    lead OTHER

Principal Investigators

  • Giuseppe Grandy, MD MSc · Centro Pediatrico Albina de Ptino

  • Richard Soria, MD · Centro Pediatrico Albina de Patino

  • Jackeline Torrez, MD · Centro Pediatrico Albina de Patino

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-01-31
Completion
2012-04-30

Countries

  • Bolivia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01577043 on ClinicalTrials.gov